Pluvicto
Ended Awarded Last action
- Contract number
- 36C24224N0280
- Awardee
-
Advanced Accelerator Applications USA Inc. UEI JNM4NBNHFE66
- Awarding agency
-
Veterans Integrated Service Network 2
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $616,784
Award facts
- Contract value 100% obligated
- $616,783.89 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Millburn, NJ 07041, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | -$1,330,955 | |
| Original award | $1,947,739 |
About this award
Advanced Accelerator Applications USA Inc., a Novartis subsidiary specializing in radiopharmaceutical manufacturing, was awarded a Firm Fixed Price Blanket Purchase Agreement (BPA) call valued at $616,783.89 for the supply of PLUVICTO (lutetium Lu 177 vipivotide tetraxetan) on February 1, 2024. The contract is funded through Veterans Integrated Service Network 2, a component of the Department of Veterans Affairs, with a performance location in Millburn, New Jersey. This award was issued under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) and carries no small business set-aside designation, reflecting the specialized nature of the product and the vendor's established status as a large-scale manufacturer of nuclear medicine solutions.
PLUVICTO is an advanced radiopharmaceutical used for targeted radioligand therapy in cancer treatment, supporting diagnostic imaging and nuclear medicine procedures across VA medical facilities. This contract call represents a continuation of the vendor's substantial federal footprint in supplying critical radiopharmaceutical products to healthcare agencies, with the ultimate completion date set for September 30, 2024. The award facilitates efficient procurement of this specialized therapeutic product to support VA patient care needs across its integrated service networks.
Quick answers
Who was awarded contract 36C24224N0280?
36C24224N0280 was awarded to Advanced Accelerator Applications USA Inc. by Veterans Integrated Service Network 2 (Veterans Health Administration) on February 1, 2024.
How much is contract 36C24224N0280 worth?
The government has obligated $616,784 on 36C24224N0280.
Is contract 36C24224N0280 an order under another contract?
Yes. 36C24224N0280 is a BPA call under 36F79719D0169-36C24223A0022, a blanket purchase agreement, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C24224N0280 competed?
The extent of competition for 36C24224N0280 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award